Among the distributors, J.P. Morgan said that it favors McKesson Corporation MCK and Cardinal Health, Inc. CAH.
“We continue to believe that MCK is underappreciated, as the distribution business continues to successfully expand generic penetration and EBIT growth continues to be the highest in the industry,” J.P. Morgan writes.
“The HCIT business is also poised for a rebound as ARRA demand increases and investments made in anticipation lap. At Cardinal, recent acquisitions, including a new foray into China, have positioned the company for longer-term growth while turnaround initiatives continue to drive margin expansion.”
Cardinal Health closed Wednesday at $38.88; McKesson Corporation closed at $72.33.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst RatingsCardinal HealthHealth CareHealth Care DistributorsJ.P. MorganMcKesson Corporation
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in